IXICO plc (LON:IXI – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 7.90 and traded as low as GBX 7.33. IXICO shares last traded at GBX 7.33, with a volume of 57,826 shares trading hands.
IXICO Stock Up 6.7%
The company has a debt-to-equity ratio of 5.22, a quick ratio of 4.90 and a current ratio of 2.83. The firm’s fifty day simple moving average is GBX 8.07 and its 200 day simple moving average is GBX 7.90. The stock has a market capitalization of £17.52 million, a price-to-earnings ratio of -4.10, a P/E/G ratio of -0.38 and a beta of 0.13.
Insider Activity at IXICO
In related news, insider Mark Warne acquired 50,006 shares of the company’s stock in a transaction that occurred on Wednesday, July 15th. The shares were acquired at an average cost of GBX 8 per share, for a total transaction of £4,000.48. 3.07% of the stock is currently owned by insiders.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Further Reading
- Five stocks we like better than IXICO
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
- Merchants Bancorp’s Rally Is Testing How Much Risk Investors Will Overlook
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
